The impact of magnesium sulfate administration on the prognosis of septic patients with hypomagnesemia: a retrospective propensity score-matched cohort study based on MIMIC-IV

Introduction This study aimed to provide a basis for optimizing clinical treatment by retrospectively analyzing the clinical characteristics of hypomagnesemia in sepsis patients and the impact of magnesium sulfate administration on their prognosis. Material and methods Based on inclusion and exclusion criteria, we included adult individuals diagnosed with sepsis and concurrent hypomagnesemia. Exposure was defined as administration of magnesium sulfate on the first day of ICU admission. The primary outcome assessed was the 28-day mortality rate. Secondary outcomes encompassed mortality rates at 90 and 365 days, the duration of mechanical ventilation, requirement for continuous renal replacement therapy (CRRT), hospital stay duration, intensive care unit (ICU) stay duration, hospital mortality, and ICU mortality. A multivariable Cox regression analysis was conducted to evaluate the relationship between sepsis with hypomagnesemia and 28-day mortality. Propensity score matching (PSM) was performed at a 1 : 1 ratio. Multivariable analysis was used to adjust for confounding factors. Results In the PSM analysis, the 28-day mortality rate appeared reduced in the magnesium sulfate treatment group relative to the untreated group (10.15% [33/3192] vs. 16.31% [53/347]). Magnesium sulfate use correlated with a decreased 28-day mortality rate (hazard ratio [HR] = 0.61; 95% CI: 0.39–0.94; p = 0.026). Magnesium sulfate administration also reduced the 90-day mortality rate (p = 0.039). Statistical analysis revealed no significant differences between magnesium sulfate administration and the use of CRRT, mechanical ventilation duration, hospital and ICU lengths of stay, or mortality rates at 365 days. Conclusions The administration of magnesium sulfate is associated with a reduced mortality rate in individuals diagnosed with sepsis and hypomagnesemia, providing theoretical support for clinical practice.

Authors

Institutions

Publication Details

Journal
Archives of Medical Science
Published
2025-05-05
DOI
https://doi.org/10.5114/aoms/203512
Primary Topic
Magnesium in Health and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of magnesium sulfate administration on the prognosis of septic patients with hypomagnesemia: a retrospective propensity score-matched cohort study based on MIMIC-IV

Jiaqiong Li, Piao Li, Shucun Liu, Miao Zhang et al.
Archives of Medical Science
Magnesium in Health and Disease
article

The impact of magnesium sulfate administration on the prognosis of septic patients with hypomagnesemia: a retrospective propensity score-matched cohort study based on MIMIC-IV

Jiaqiong Li, Piao Li, Shucun Liu, Miao Zhang, Wei Ye, Xing Tang
article en

Abstract

Introduction This study aimed to provide a basis for optimizing clinical treatment by retrospectively analyzing the clinical characteristics of hypomagnesemia in sepsis patients and the impact of magnesium sulfate administration on their prognosis. Material and methods Based on inclusion and exclusion criteria, we included adult individuals diagnosed with sepsis and concurrent hypomagnesemia. Exposure was defined as administration of magnesium sulfate on the first day of ICU admission. The primary outcome assessed was the 28-day mortality rate. Secondary outcomes encompassed mortality rates at 90 and 365 days, the duration of mechanical ventilation, requirement for continuous renal replacement therapy (CRRT), hospital stay duration, intensive care unit (ICU) stay duration, hospital mortality, and ICU mortality. A multivariable Cox regression analysis was conducted to evaluate the relationship between sepsis with hypomagnesemia and 28-day mortality. Propensity score matching (PSM) was performed at a 1 : 1 ratio. Multivariable analysis was used to adjust for confounding factors. Results In the PSM analysis, the 28-day mortality rate appeared reduced in the magnesium sulfate treatment group relative to the untreated group (10.15% [33/3192] vs. 16.31% [53/347]). Magnesium sulfate use correlated with a decreased 28-day mortality rate (hazard ratio [HR] = 0.61; 95% CI: 0.39–0.94; p = 0.026). Magnesium sulfate administration also reduced the 90-day mortality rate (p = 0.039). Statistical analysis revealed no significant differences between magnesium sulfate administration and the use of CRRT, mechanical ventilation duration, hospital and ICU lengths of stay, or mortality rates at 365 days. Conclusions The administration of magnesium sulfate is associated with a reduced mortality rate in individuals diagnosed with sepsis and hypomagnesemia, providing theoretical support for clinical practice.

Archives of Medical Science
Xuzhou Medical College (CN), Xuzhou Central Hospital (CN), Jingning County People's Hospital (CN)
Openalex Percentile: Top 88%
Magnesium in Health and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.